Synopsys Q4 Earnings Surpass Estimates, Revenues Rise Y/Y

12.12.25 16:33 Uhr

Werte in diesem Artikel
Aktien

31,00 JPY 0,00 JPY 0,00%

392,95 EUR 6,25 EUR 1,62%

Indizes

25.132,9 PKT 65,7 PKT 0,26%

23.111,5 PKT 54,1 PKT 0,23%

6.800,3 PKT -16,3 PKT -0,24%

Synopsys SNPS reported non-GAAP earnings of $2.90 per share for the fourth quarter of fiscal 2025, which beat the Zacks Consensus Estimate by 3.94%. The bottom line decreased 14.7% on a year-over-year basis.Synopsys’ earnings beat the Zacks Consensus Estimate thrice and missed once in the trailing four quarters, with the average surprise being 2.1%.Synopsys’ fiscal fourth-quarter revenues jumped 37.8% year over year to $2.25 billion, beating the Zacks Consensus Estimate by 0.17%. The top line was primarily driven by an increase in revenues of Time-Based Product and Upfront Product businesses.Synopsys’ Q4 DetailsIn the license-type revenue group, Time-Based Product revenues of $940.7 million (representing 41.7% of total revenues) increased 12.7% year over year. Upfront Product revenues (27.3% of total) rose 18.1% to $615.4 million. Maintenance and Service revenues (31.0% of total) surged to $698.8 million, up sharply from the year-ago quarter’s $280.1 million.Synopsys, Inc. Price, Consensus and EPS Surprise Synopsys, Inc. price-consensus-eps-surprise-chart | Synopsys, Inc. QuoteSegment-wise, Design Automation revenues, which include EDA, Ansys and Other, were $1.85 billion, representing 81.9% of total revenues and up 65.2% from the prior-year quarter. Design IP revenues were $407.2 million, down from $517.8 million a year ago. With the addition of Ansys, the Simulation & Analysis group is now incorporated into the EDA segment, beginning the third quarter of fiscal 2025. Other revenues were $44.7 million, representing 2.0% of total revenues. Ansys contributed 29.6% of the total revenues. Geographically, Synopsys generated $1.05 billion from North America (46% of total) and $361.4 million from Europe (16%). Revenues from Korea (11%), China (10%) and Other regions (17%) were $236.9 million, $235.6 million, and $373.7 million, respectively.The non-GAAP operating margin for the quarter was 36.5%, down from 40 basis points from the year-ago period.Within segments, Design Automation’s adjusted operating margin improved to 41.5%, up from 37% a year earlier, while the Design IP segment’s adjusted margin contracted to 13.8%, down from 36.7% last year.Synopsys’ Balance Sheet & Cash FlowSynopsys ended the fourth quarter of fiscal 2025 with $2.96 billion in cash, cash equivalents and short-term investments, up from $2.59 billion in the prior quarter. Total long-term debt was $13.46 billion.During the fourth quarter of fiscal 2025, Synopsys generated $640 million in operating cash flow. In fiscal 2025, SNPS generated $1.52 billion in operating cash flow.SNPS’ Guidance for FY26For fiscal 2026, Synopsys expects revenues in the range of $9.56-$9.66 billion, including $2.9 billion of expected Ansys revenues. The Zacks Consensus Estimate for SNPS’ fiscal 2026 revenues is pegged at $9.73 billion, indicating year-over-year growth of 38%.Non-GAAP EPS is expected between $14.32 and $14.40. Non-GAAP expenses are projected to be in the range of $5.69-$5.75 billion. The Zacks Consensus Estimate for SNPS’ fiscal 2026 earnings is pegged at $14.01, indicating year-over-year growth of 8.5%.For the first quarter of fiscal 2026, Synopsys expects revenues between $2.365 billion and $2.415 billion. The Zacks Consensus Estimate for SNPS’ first-quarter fiscal 2026 revenues is pegged at $2.38 billion, indicating year-over-year growth of 63.8%.Management expects non-GAAP EPS between $3.52 and $3.58. The Zacks Consensus Estimate for SNPS’ first-quarter fiscal 2026 earnings is pegged at $3.36, indicating a year-over-year rise of 10.9%.SNPS’ Zacks Rank and Other Stocks to ConsiderCurrently, SNPS carries a Zacks Rank #2 (Buy).Amphenol APH, NVIDIA NVDA and CommScope COMM are some other top-ranked stocks in the broader Zacks Computer & Technology sector.Amphenol, NVIDIA and CommScope sport a Zacks Rank #1 (Strong Buy) each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.Amphenol’s shares have appreciated 88.4% in the trailing 12 months. The Zacks Consensus Estimate for Amphenol’s 2025 earnings is pegged at $3.29 per share, up 7 cents over the past 30 days, indicating an increase of 74.07% year over year.NVIDIA shares have appreciated 33.8% in the trailing 12 months. The Zacks Consensus Estimate for NVIDIA’s 2025 earnings is pegged at $4.62 per share, up 16 cents over the past 30 days, indicating an increase of 54.52% year over year.CommScope shares have appreciated 250.2% in the trailing 12 months. The Zacks Consensus Estimate for CommScope’s 2025 earnings is pegged at $1.64 per share, unchanged over the past 30 days, indicating an increase of 5566.67% year over year.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Amphenol Corporation (APH): Free Stock Analysis Report NVIDIA Corporation (NVDA): Free Stock Analysis Report Synopsys, Inc. (SNPS): Free Stock Analysis Report CommScope Holding Company, Inc. (COMM): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Synopsys und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Q4

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q4

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Synopsys Inc.

Wer­bung

Analysen zu Synopsys Inc.

DatumRatingAnalyst
22.08.2019Synopsys BuyNeedham & Company, LLC
03.04.2019Synopsys BuyNeedham & Company, LLC
28.03.2019Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyThe Benchmark Company
DatumRatingAnalyst
22.08.2019Synopsys BuyNeedham & Company, LLC
03.04.2019Synopsys BuyNeedham & Company, LLC
28.03.2019Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyThe Benchmark Company
DatumRatingAnalyst
09.09.2015Synopsys HoldThe Benchmark Company
04.12.2008Synopsys UpgradeCitigroup Corp.
02.02.2007Synopsys neutralDA Davidson
31.01.2007Update Synopsys Inc.: NeutralDA Davidson
30.11.2006Synopsys holdDeutsche Securities
DatumRatingAnalyst
21.08.2008Synopsys DowngradeCitigroup Corp.
24.06.2005Synopsys underweightPrudential Financial

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Synopsys Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen